method. 10) Tectoridin (Purity, ϩ . TLC TLC of tectoridin and its metabolite tectorigenin was performed on silica gel plates (Merck, Silica-gel 60F254) with CHCl 3 /MeOH (4 : 1). The chromatograms of these compounds were quantitatively assayed with a Shimadzu CS-9301 TLC scanner.
Animals Male Sprague-Dawley (SD) rats and Institute of Cancer Research (ICR) mice were supplied from Daehan Experimental Animal Breeding Center. All animals were housed in wire cages at 20-22°C and 50Ϯ10% humidity, fed standard laboratory chow (Samyang Feed Production Co.), and allowed water ad libitum. All procedures relating to animals and their care conformed with the international guidelines Principles of Laboratory Animal Care (NIH publication no. 85-23, revised 1985) and Guiding Principles for the Care and Use of Laboratory Animals of Kyung Hee University, Korea.
Isolation of Metabolites To obtain the metabolites of tectoridin by human intestinal bacteria, a reaction mixture was prepared containing tectoridin 2.0 g and 5 g of fresh human feces in a final volume of 500 ml of anaerobic dilution medium in an anaerobic glove box (Coy Laboratory Products Inc., MI, U.S.A.). The mixture was incubated at 37°C for 24 h and the reaction mixture was extracted three times with ethyl acetate. The EtOAc-soluble portion of the reaction mixture was dried on a rotary evaporator under reduced pressure and subjected to silica gel column chromatography (2.5ϫ15 cm) with CHCl 3 /MeOH (10 : 1-10 : 2). Tectoridin and tectorigenin (0.19 g) were obtained from these fractions incubated with tectoridin. Tectoridin and tectorigenin were identified according to the previously reported method. 6) inhibitory activity of test agents against the release of b-hexosaminidase from RBL-2H3 cells was evaluated according to the method of Choi et al. 11) RBL-2H3 cells were grown in DMEM supplemented with 10% fetal bovine serum and Lglutamine. Before experiments, the cells were dispensed into 24-well plates at the concentration of 5ϫ10 5 cells/well using the medium containing 0.5 mg/ml of mouse monoclonal IgE and were incubated overnight at 37°C in 5% CO 2 for sensitization. The cells were washed with 500 ml of siraganian buffer [119 mM NaCl, 5 mM KCl, 0.4 mM MgCl 2 , 25 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid), and 40 mM NaOH at pH 7.2] and incubated in 160 ml of siraganian buffer containing 5.6 mM glucose, 1 mM CaCl 2 , and 0.1% BSA for additional 10 min at 37°C. Then cells were exposed to 40 ml of test agents for 20 min, followed by the treatment with 20 ml of antigen (DNP-HSA, 1 mg/ml) for 10 min at 37°C to activate cells to evoke allergic reactions (degranulation). The reaction was stopped by cooling in an ice bath for 10 min. The reaction mixture was centrifuged at 2000 rpm for 10 min and 25 ml aliquots of supernatant were transferred to 96-well plates and incubated with 25 ml of substrate (1 mM
The reaction was stopped by adding 200 ml of 0.1 M Na 2 CO 3 /NaHCO 3 and the absorbance measured by ELISA reader at 405 nm.
PCA Reaction An IgE-dependent PCA reaction was measured according to the previous method of Katayama et al.
12) The male ICR mice (22-25 g) were injected intradermally with 10 mg of anti-DNP IgE into each of two dorsal skin sites that had been shaved 48 h earlier. The sites were outlined with a water-insoluble red marker. Forty-eight hours later, each mouse received an injection of 200 ml of 3% Evans blue PBS containing 200 mg of DNP-HSA via the tail vein. Test compounds were administered 1 h prior to the DNP-HSA injection. Thirty minutes after the DNP-HSA injection, the mice were killed and their dorsal skins removed for measurement of the pigmented area. After extraction with 1 ml of 1.0 N KOH and 4 ml of a mixture of acetone and 0.6 N phosphoric acid (13 : 5) , the amount of dye was determined colorimetrically (absorbance at 620 nm).
Assay of Antioxidative Activity 1,1-Diphenyl-2-picrylhydrazyl (DPPH) radical scavenging, superoxide anion radical generation, and xanthine oxidase (XO)-inhibitory activities of compounds isolated were measured according to the method of Xiong et al. 13) Nitric Oxide Analysis Nitric oxide (NO) was determined by measuring the amount of nitrite from cell culture supernatant using the Griess reagent according to the manufacturer's protocol. 14) RAW 264.7 cells were stimulated with lipopolysaccharide (LPS) (1 mg/ml) and test compounds for 24 h. Cells were briefly centrifuged, and 150 ml of cell culture supernatant was mixed with 150 ml of Griess reagent and incubated 10 min at room temperature (light protected). The absorbance was measured using an ELISA reader at 540 nm against a calibration curve with sodium nitrate as a standard.
Pharmacokinetic Study Tectoridin (40 mg/rat) was orally administered to three male SD rats (200-220 g), and urine was collected continuously at 4, 8, 12, 24, 36, 48, and 60 h postdosing. The urine samples were treated according to the previously reported method.
15) The urine (3 ml) was incubated at 37°C for 20 h with b-glucuronidase (10000 units, Sigma Co. MO, U.S.A.) in 1 ml of 1 M sodium acetate buffer (pH 4.5), and then applied on a preconditioned C 18 solidphase column (Sep-Pak, Waters Co., U.S.A.) preconditioned with 6 ml of 95% ethanol and 10 ml of distilled water. The column was washed with 4 ml of 10% methanol in distilled water and then eluted with 2 ml of methanol.
The eluted sample was analyzed by HPLC (Waters System: column, m-Bondapak C 18 (3.9ϫ300 mm); elution solvent, methanol/water/glacial acetic acid (55 : 42.5 : 2.5); elution rate, 1.0 ml/min; detection wavelength, 280 nm) (Fig. 2) . The retention times of metabolites were as follows: tectoridin, 6.41 min; tectorigenin, 11.45 min; and ponciretin (internal standard), 18.36 min.
Statistical Analysis All the data from the in vivo experiments are expressed as meanϮstandard deviation, and the statistical significance of differences was determined using Duncan's multiple-range test. 1100 Vol. 27, No. 7
Fig. 2. HPLC Chromatogram (a) and Time Course of Tectorigenin Concentration (b) in the Urine of SD Rats
Tectoridin was administered to rats (200 mg/kg), and total urine was collected in metabolic cages (at 4, 8, 12, 24, 36, 48, 60 h). The urine was incubated for 24 h at 37°C with bglucuronidase. The level of tectorigenin was measured using HPLC (Waters system: column, m-Bondapak C 18 (3.9ϫ300 nm); elution solvent, methanol/water/glacial acetic acid (55 : 42.5 : 2.5); elution rate, 1.0 ml/min; detection wavelength, 280 nm). The retention times of metabolites were as follows: tectoridin, 6.41 min; tectorigenin, 11.45 min; and ponciretin (internal standard), 18.36 min.
RESULTS

Metabolism of Tectoridin by Human Fecal Bacteria
When tectoridin was incubated with human feces, it was metabolized to tectorigenin, as previously reported. 9) To understand the biotransformation of tectoridin in the entire body, tectoridin (250 mg/kg) was orally administered to rats and the compounds in urine were periodically analyzed by HPLC after b-glucuronidase hydrolysis. As shown in Fig. 1 , the main compound detected in urine was tectorigenin. The total excreted was 0.8-1% of the orally administered tectoridin dose within 24 h. However, tectoridin was not detected.
Protective Effect of Tectoridin against the PCA Reaction To isolate antiallergic compounds from natural products, isoflavones from the flowers of P. thungergiana were orally administered to mice and their inhibitory activities against the in vivo PCA reaction were measured. Tectoridin showed the most potent inhibition. 4) Therefore we measured the inhibitory activity on b-hexosaminidase release from RBL-2H3 cells induced by IgE (Table 1) . Tectoridin showed weak inhibitory activity. However, tectorigenin exhibited potent inhibition, with an IC 50 value of 0.193 mM. Therefore we measured the PCA-inhibitory activity of tectorigenin (Table  2) . Intraperitoneally administered tectorigenin showed potent inhibitory activity and significantly inhibited the PCA reaction at doses of 50 mg/kg with inhibitory activity of 98Ϯ14.4%. However, intraperitoneally administered tectoridin had weak inhibitory activity.
Inhibition of NO Production and Active Oxygen Radical-Scavenging Activity of Tectoridin and Tectorigenin
When the effects of tectoridin and tectorigenin on the activity of hyaluronidase and their active oxygen radical-scavenging activity were investigated, these substances (0.2 mM) showed almost no inhibition of the activation of hyaluronidase and scavenging of active oxygens (Table 3) .
The stimulation of RAW 264.7 cells with LPS also induced NO production. Tectoridin and tectorigenin weakly inhibited NO production in LPS-stimulated RAW 264.7 cells, although L-NMMA, which is a representative inhibitor, potently inhibited the enzyme activity (Table 3) .
DISCUSSION
Allergic diseases such as asthma and atopic dermatitis are based on IgE-mediated pharmacologic processes of a variety of cell populations such as mast cell and basophils. 16) Degranulation of mast cells and basophils with antigencrosslinked IgE causes anaphylaxis.
17) The present study evaluated the inhibitory activity of isoflavones, which are the main components in the flower of P. thunbergiana, against the PCA reaction. Orally administered tectoridin potently inhibited the PCA reaction. However, when their glycosides were administered intraperitoneally, PCA-inhibitory activity did not increase. Tectorigenin potently inhibited the PCA reaction. The inhibitory activity was more potent than that of other isoflavones, such as daidzein, which was also reported to be a PCA inhibitor. 18) Tectorigenin exhibited the most potent inhibitory activity. Although its potency is weaker than that of azelastine (10 mg/kg i.p.), it potently inhibited the PCA reaction. These results confirmed that tectorigenin exhibits potent inhibitory activity against b-hexosaminidase release from RBL-2H3 cells induced by IgE, but its glycoside tectoridin showed weak inhibitory activity. Tectorigenin not only weakly inhibited NO production, but also scavenged in vitro active oxygens, as in the previous reports. 10, 19) Tectoridin and tectorigenin did not inhibit the activation of hyaluronidase at a concentration of 5 mM. These results suggest that the PCA-inhibitory mechanism of tectorigenin may be due to membrane stabilization and free radical-scavenging activity.
We found that tectoridin was quickly metabolized to tectorigenin when incubated with human intestinal bacteria in a previous study. 9) In the present study, we also found that when tectoridin was orally administered to rats, tectorigenin was detected in urine after b-glucuronidase hydrolysis. These results suggest that the isoflavone glycoside tectoridin can be easily transformed into its aglycone by intestinal microflora and the transformed aglycone may inhibit the PCA reaction. Therefore we believe that tectoridin is a prodrug that has antiallergic properties and that tectorigenin is a candidate the therapeutic agent for the treatment of IgE-induced atopic allergy. 
